6.910USD-1.99%Mkt Cap: 269.42M USDP/E: —Last update: 2026-06-01
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considere…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap269.42M USD
Enterprise Value48.93M USD
Revenue (TTM)5.74M USD
Gross Profit-135.81M USD
Net Income (TTM)-143.75M USD
Revenue/Share0.1380 USD
Last Price6.910 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees152
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.08
PEG—
EV/EBITDA-0.28
EV/Revenue8.53
P/S47.83
P/B0.83
EPS (TTM)-4.00
EPS (Forward)-3.41
52W Range
4.93017% of range16.45
52W High16.45 USD
52W Low4.930 USD
Profitability
Gross Margin0.00%
Oper. Margin-4834.63%
EBITDA Margin0.00%
Profit Margin-565.48%
ROE-46.96%
ROA-38.09%
Growth
Revenue Growth-95.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-128.51M USD
CapEx (TTM)1.04M USD
FCF Margin-1313.72%
FCF Yield-27.98%
Net Debt-205.11M USD
Net Debt/EBITDA1.19
Balance Sheet
Debt/Equity0.17
Current Ratio13.90
Quick Ratio13.40
Book Value/Sh8.504 USD
Cash/Share7.073 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)19.50 USD
Target Range10.00 USD – 25.00 USD
# Analysts4
Ownership
Shares Out.38.82M
Float19.47M
Insiders12.31%
Institutions78.41%
Short Interest
Short Ratio2.7d
Short % Float6.04%
Short % Out.3.88%
Shares Short1.51M
Short (prev mo.)852.25K
Technical
SMA 5011.16 (-38.1%)
SMA 2009.370 (-26.3%)
Beta-0.09
S&P 52W Chg27.70%
Avg Vol (30d)526.48K
Avg Vol (10d)384.65K
Technical Indicators
RSI (14)36.9
MACD-1.5280
MACD Signal-1.6263
MACD Hist.+0.0983
BB Upper15.77 USD
BB Middle8.397 USD
BB Lower1.024 USD
BB Width175.61%
ATR (14)0.8440 USD
Vol Ratio (20d)0.29x